Cite
HARVARD Citation
Lee, C. et al. (2019). Efficacy and safety of mirabegron, a β3‐adrenoceptor agonist, in patients with detrusor hyperactivity and impaired contractility. LUTS. 11 (2), pp. O93-O97. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lee, C. et al. (2019). Efficacy and safety of mirabegron, a β3‐adrenoceptor agonist, in patients with detrusor hyperactivity and impaired contractility. LUTS. 11 (2), pp. O93-O97. [Online].